05/09/2018 - 08:55

Pharmaust in preliminary dog drug tests

05/09/2018 - 08:55

Bookmark

Save articles for future reference.

Pharmaust will complete preliminary clinical trials on dogs in the coming weeks to help determine the required dosage for its newly reformulated Monepantel tablets and to confirm that it is non-toxic. The company will also start a Phase I “pharmacokinetic study” with the new tablets during the fourth quarter and it will also follow this up with initiation of its long awaited Phase II clinical trials.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options